Product image of Metsunix (Metformin Hydrochloride, Sitagliptin) supplied by GNH India

Metsunix

Active Ingredient:
Metformin Hydrochloride, Sitagliptin
Origin:
EU

Metsunix (Metformin Hydrochloride, Sitagliptin)

Metformin Hydrochloride and Sitagliptin, the active ingredient in Metsunix, is a biguanide/DPP‑4 inhibitor presented as an oral tablet for oral use. It treats type 2 diabetes mellitus in adult patients, helping to lower blood glucose levels when used as part of a comprehensive diabetes management plan.

GNH India supplies Metsunix as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Adamed Laboratorios S.L.U.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Metsunix combines metformin and sitagliptin to improve glycaemic control in patients with type 2 diabetes mellitus. It is used as part of a broader therapeutic regimen that may include diet and exercise.

  • Type 2 diabetes mellitus: improves fasting and post‑prandial glucose levels.
  • Inadequate control with metformin alone: provides additional glucose‑lowering effect.
  • Adjunct to lifestyle modification: supports overall diabetes management when diet and exercise are insufficient.

How It Works

  • Metformin decreases hepatic gluconeogenesis and enhances peripheral insulin sensitivity, while sitagliptin inhibits the enzyme dipeptidyl peptidase‑4 (DPP‑4), leading to increased endogenous incretin levels that stimulate glucose‑dependent insulin secretion and suppress glucagon release. The combined actions result in reduced blood glucose concentrations.

Side Effects

Metsunix may cause a range of adverse reactions, from mild to serious. Awareness of common and rare side effects helps clinicians monitor patients appropriately.

Common Side Effects

  • Nausea: mild to moderate gastrointestinal discomfort.
  • Diarrhea: frequent loose stools, often transient.
  • Abdominal pain: cramp‑like sensations in the stomach area.
  • Headache: mild to moderate intensity.
  • Upper respiratory tract infection: symptoms of cold or mild flu.
  • Hypoglycaemia (when combined with other glucose‑lowering agents): dizziness, sweating, tremor.

Serious or Rare Side Effects

  • Lactic acidosis: severe metabolic disturbance, rare but life‑threatening.
  • Pancreatitis: acute abdominal pain with elevated enzymes.
  • Severe allergic reactions: rash, angioedema, anaphylaxis.
  • Hepatic dysfunction: abnormal liver enzymes, jaundice.
  • Renal impairment worsening: reduced kidney function may exacerbate metformin accumulation.

Precautions & Warnings

Before prescribing Metsunix, clinicians should evaluate patient‑specific factors and monitor for potential complications.

  • Renal function assessment: ensure adequate glomerular filtration before initiation.
  • Hepatic function monitoring: avoid use in patients with significant liver disease.
  • Cardiovascular status review: caution in congestive heart failure due to lactic acidosis risk.
  • Elderly patients: start at lower dose and monitor for hypoglycaemia.
  • Concomitant hypoglycaemic agents: adjust doses to prevent low blood sugar.
  • Store at room temperature: keep in original container, protect from moisture and heat.

Avoid Interactions

Metsunix can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid)

  • Iodinated contrast agents: may precipitate metformin‑associated lactic acidosis.
  • Cimetidine: can increase metformin plasma concentrations.
  • Rifampicin: reduces sitagliptin levels, decreasing efficacy.

Moderate Interactions (Monitor Closely)

  • Beta‑blockers: may mask hypoglycaemia symptoms.
  • Diuretics: can affect renal clearance of metformin, requiring dose adjustment.

Frequently Asked Questions

Metsunix is an oral antidiabetic medication that combines metformin hydrochloride and sitagliptin hydrochloride. It is prescribed to improve blood glucose control in adults with type 2 diabetes mellitus, often when metformin alone does not achieve target levels.

Metformin reduces hepatic glucose production and increases insulin sensitivity in muscle and fat tissue. Sitagliptin blocks the enzyme DPP‑4, which raises levels of incretin hormones that stimulate insulin release and suppress glucagon, enhancing glucose‑dependent insulin secretion.

The dose of Metsunix is individualized by the prescribing healthcare professional based on the patient’s clinical condition, renal function, and response to therapy. Patients should follow the dosage instructions provided by their prescriber and not adjust the dose on their own.

The safety of Metsunix in pregnancy and lactation has not been fully established. Metformin is sometimes used during pregnancy under specialist guidance, while sitagliptin is generally avoided. Women who are pregnant, planning pregnancy, or breastfeeding should discuss risks and alternatives with their healthcare provider.

To request Metsunix, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Metsunix offers the combined benefits of a biguanide (metformin) and a DPP‑4 inhibitor (sitagliptin) in a single tablet, simplifying regimens compared with taking separate agents. It provides greater glucose‑lowering efficacy than metformin alone and avoids the weight gain associated with some sulfonylureas or insulin.

Metsunix tablets should be stored at room temperature, below 25 °C, in the original packaging to protect them from moisture and light. Keep the product out of reach of children and do not use if the packaging is damaged.

Metsunix is taken orally, usually with meals to reduce gastrointestinal discomfort. The tablet should be swallowed whole with a glass of water. Patients should follow the timing and frequency prescribed by their healthcare professional.

The most serious risks include lactic acidosis, a rare but potentially fatal condition linked to metformin, and pancreatitis, which can occur with sitagliptin. Patients should seek immediate medical attention for symptoms such as severe abdominal pain, rapid breathing, or unexplained fatigue.

Metsunix is contraindicated in patients with severe renal impairment, significant hepatic disease, or a history of lactic acidosis. It should also be avoided in individuals with known hypersensitivity to metformin, sitagliptin, or any excipients in the tablet formulation.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Metformin Hydrochloride, Sitagliptin

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT